Verona Pharma plc (VRNA) has a market capitalization of $72.68B and trades at $106.91. The 52-week range is 31.09-106.93.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -49.5, Earnings Per Share (EPS) of $-2.16, annual revenue of $42.28M.
The stock has a beta of 0.05, operates in the Healthcare sector.
